Obesity: a main factor of metabolic syndrome?
- PMID: 16953145
Obesity: a main factor of metabolic syndrome?
Abstract
The metabolic syndrome (MS) is a common metabolic disorder that has been recently related to the increasing prevalence of obesity. The disorder is defined in various ways, but in the near future a new definition(s) will be applicable worldwide. The pathophysiology has been largely attributed, in the past years, to insulin-resistance, even if several epidemiological and pathophysiological data are attractive to indicate visceral obesity as a main factor in the occurrence of the MS, promoting new definitions and re-evaluation of the pathogenesis of this syndrome. In this review, we have analyzed the role of visceral obesity in the new definition of the MS such as the pathophysiological role of the abnormal fat distribution in the occurrence of this syndrome. In view of this, relationships between visceral obesity, free fatty acids, dyslipidaemia and insulin-resistance have been reported. In addition, the effects of some adipocytokines and other proinflammatory factors produced by fat accumulation on the appearance of the MS have been also emphasized. Finally, according to recommendations of several international societies, the role of the life-style change and of the weight loss in the prevention and treatment both of obesity and of other associated risk factors has been analyzed.
Similar articles
-
The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.Semin Vasc Med. 2002 Feb;2(1):45-57. doi: 10.1055/s-2002-23095. Semin Vasc Med. 2002. PMID: 16222595 Review.
-
Is visceral obesity the cause of the metabolic syndrome?Ann Med. 2006;38(1):52-63. doi: 10.1080/07853890500383895. Ann Med. 2006. PMID: 16448989 Review.
-
Visceral obesity and metabolic syndrome: two faces of the same medal?Intern Emerg Med. 2010 Apr;5(2):111-9. doi: 10.1007/s11739-009-0332-6. Epub 2009 Dec 9. Intern Emerg Med. 2010. PMID: 19998063 Review.
-
Insulin resistance: trigger or concomitant factor in the metabolic syndrome.Panminerva Med. 2006 Mar;48(1):3-12. Panminerva Med. 2006. PMID: 16633326 Review.
-
Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?Expert Rev Cardiovasc Ther. 2006 Nov;4(6):871-95. doi: 10.1586/14779072.4.6.871. Expert Rev Cardiovasc Ther. 2006. PMID: 17173503 Review.
Cited by
-
Tirzepatide against obesity and insulin-resistance: pathophysiological aspects and clinical evidence.Front Endocrinol (Lausanne). 2024 Jun 24;15:1402583. doi: 10.3389/fendo.2024.1402583. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38978621 Free PMC article. Review.
-
The association of fasting blood glucose (FBG) and waist circumference in northern adults in Iran: a population based study.J Diabetes Metab Disord. 2014 Jan 6;13(1):2. doi: 10.1186/2251-6581-13-2. J Diabetes Metab Disord. 2014. PMID: 24393143 Free PMC article.
-
The correlation between educational levels and central obesity in the north of Iran: An epidemiologic study.ARYA Atheroscler. 2013 Jun;9(4):217-22. ARYA Atheroscler. 2013. PMID: 23970916 Free PMC article.
-
Quantitative loci regulating plasma levels of gamma glutamyl transferase and albumin and their genetic correlations with cardiovascular risk factors.Exp Biol Med (Maywood). 2009 Dec;234(12):vi, 1519-24. doi: 10.3181/0903-RM-115. Exp Biol Med (Maywood). 2009. PMID: 19934372 Free PMC article.
-
Effects of serum uric acid levels on the arginase pathway in women with metabolic syndrome.Ir J Med Sci. 2016 Feb;185(1):259-63. doi: 10.1007/s11845-015-1347-9. Epub 2015 Aug 2. Ir J Med Sci. 2016. PMID: 26232927
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous